Concurrently, METTL1 upregulates PKM2 expression and glycolysis; the nuclear translocation of the PKM2 dimer directly activates CD155 transcription, reducing CD16+ NK cell infiltration and further facilitating immune escape in CRC [77]. This evidence concerns the gene PKM and colorectal carcinoma.